Showing results (91-100 of 109) with videos related to
Sort By:
Pageof 11
Journal of Psychoactive Drugs|July 20, 2016
Sexual Abuse and its Relation to Chronic Pain among Women from a Methadone Maintenance Clinic versus a Sexual Abuse Treatment CenterEinat Peles, Zivya Seligman, Miki Bloch, et al.Journal of Addictive Diseases|May 21, 2024
Different characteristics but comparable hypertension rates between two MMT "twin" clinicsMiriam Adelson, Dinita Smith, Anat Sason, et al.Plos One|June 29, 2018
A non-coding CRHR2 SNP rs255105, a cis-eQTL for a downstream lincRNA AC005154.6, is associated with heroin addictionOrna Levran, Joel Correa da Rosa, Matthew Randesi, et al.Annals of Human Genetics|April 29, 2014
Drug addiction and stress-response genetic variability: association study in African AmericansOrna Levran, Matthew Randesi, Yi Li, et al.Pharmacogenomics|October 5, 2017
The μ-opioid receptor nonsynonymous variant 118A>G is associated with prolonged abstinence from heroin without agonist treatmentOrna Levran, Einat Peles, Matthew Randesi, et al.Journal of Electrocardiology|September 17, 2013
Response of QT interval in methadone maintenance treated patients to the rapid changes in heart rate provoked by brisk standing: comparison to healthy controls and patients with long QT syndromeOrit Kliuk Ben Bassat, Einat Peles, Shaul Schreiber, et al.Journal of Psychoactive Drugs|January 1, 2014
Methadone maintenance treatment experience in Macao--prospective follow-up for initial 4.5 yearsMiriam Adelson, Hon Wai Wilson, Vong Yim Mui Celeste, et al.Annals of Human Genetics|April 16, 2015
Overlapping dopaminergic pathway genetic susceptibility to heroin and cocaine addictions in African AmericansOrna Levran, Matthew Randesi, Joel Correa da Rosa, et al.The Israel Journal of Psychiatry and Related Sciences|April 5, 2015
The Prevalence of Alcohol, Substance and Cigarettes Exposure among Pregnant Women within a General Hospital and the Compliance to Brief Intervention for Exposure ReductionEinat Peles, Anat Sason, Miki Bloch, et al.Pharmacogenomics|May 9, 2013
Association of genetic variation in pharmacodynamic factors with methadone dose required for effective treatment of opioid addictionOrna Levran, Einat Peles, Matthew Randesi, et al.Pageof 11